Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.47 | 2.47 | 0.00 |
Stocks | 97.53 | 97.53 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.66 | 19.66 |
Price to Book | 3.96 | 4.55 |
Price to Sales | 1.47 | 2.64 |
Price to Cash Flow | 15.98 | 17.59 |
Dividend Yield | 1.62 | 1.06 |
5 Years Earnings Growth | 10.39 | 13.85 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.81 | 99.66 |
Consumer Defensive | 0.07 | 0.43 |
Financial Services | 0.06 | 0.49 |
Industrials | 0.05 | 0.05 |
Technology | 0.01 | 0.15 |
Number of long holdings: 419
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.68 | 811.00 | +0.07% | |
UnitedHealth | US91324P1021 | 8.00 | 547.61 | -0.10% | |
AbbVie | US00287Y1091 | 4.86 | 189.95 | -0.10% | |
J&J | US4781601046 | 4.48 | 153.31 | +0.95% | |
Merck&Co | US58933Y1055 | 4.12 | 88.91 | -10.90% | |
Thermo Fisher Scientific | US8835561023 | 3.40 | 584.92 | -1.49% | |
Abbott Labs | US0028241000 | 3.37 | 127.76 | -0.54% | |
Intuitive Surgical | US46120E6023 | 3.17 | 578.47 | -0.01% | |
Pfizer | US7170811035 | 2.57 | 25.78 | -1.62% | |
Danaher | US2358511028 | 2.55 | 212.46 | -0.84% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 714.4B | 23.76 | 7.88 | - | ||
Vanguard 500 Index Admiral | 562.19B | 24.97 | 8.89 | 13.06 | ||
Vanguard Total Stock Market Admiral | 406.82B | 23.74 | 7.86 | 12.49 | ||
Vanguard Total Intl Stock Index Inv | 201.2B | 5.09 | 0.61 | 5.00 | ||
Vanguard 500 Index Institutional Se | 200.46B | 25.00 | 8.93 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review